ライフサイエンスコーパス: treatment effectiveness

1 entify independent variables associated with treatment effectiveness.

2 tes improved diagnosis and the evaluation of treatment effectiveness.

3 should be treated first in order to increase treatment effectiveness.

4 MRD diagnostics becomes essential to assess treatment effectiveness.

5 baseline IOP was the strongest predictor of treatment effectiveness.

6 neous IFNbeta injection did not enhance GAS6 treatment effectiveness.

7 s the absence of consensus on measurement of treatment effectiveness.

8 e may offer novel targets or measurements of treatment effectiveness.

9 ays after induction chemotherapy to evaluate treatment effectiveness.

10 ability of studies that examine chemotherapy treatment effectiveness.

11 es not remove all biases from evaluations of treatment effectiveness.

12 trogen blockade might thus be a predictor of treatment effectiveness.

13 xed results of previous research and improve treatment effectiveness.

14 is shown to significantly alter the overall treatment effectiveness.

15 responding to radiation and therefore reduce treatment effectiveness.

16 t oxygen, causing acute hypoxia and limiting treatment effectiveness.

17 Results were sensitive to treatment effectiveness, absolute excess risk for CHF, a

18 Treatment effectiveness analyses that were stratified by

19 14% (4-28) if the new regimen affected only treatment effectiveness and by 11% (3-24) if it affected

20 e and growth of benign and malignant tumors, treatment effectiveness and costs, and patient outcomes.

21 The model incorporated RCC presence, treatment effectiveness and costs, and short- and long-t

22 Further research is required to examine treatment effectiveness and efficiency.

23 ion) and has implications for assessments of treatment effectiveness and healthcare quality, especial

24 ngle-level intervention (usual care [UC]) on treatment effectiveness and incremental cost-effectivene

25 are patients led to substantial increases in treatment effectiveness and moderate increases in costs.

26 marker had sufficient information to predict treatment effectiveness and prognosis.

27 ts to specific therapies and then to monitor treatment effectiveness and safety are currently being r

28 ice-based research, and the determination of treatment effectiveness and the factors required for suc

29 pecific medical and surgical treatments, (3) treatment effectiveness, and (4) population trends in ma

30 allowing timely diagnosis, verifications of treatment effectiveness, and developments of new medicin

31 is review is to examine service utilization, treatment effectiveness, and future directions for adole

32 of topics, including epidemiology, genetics, treatment effectiveness, and health policy.

33 age underlying causes, follow up to evaluate treatment effectiveness, and offer opioids in advanced c

34 h standard diagnostic work-up accuracy, drug treatment effectiveness, and version of the Health Utili

35 f tuberculosis without treatment, and 20-60% treatment effectiveness, approximately 4,000-11,000 tube

36 New methods of assessing early treatment effectiveness are being developed.

37 ale, class 1 randomised controlled trials on treatment effectiveness are scarce.

38 ive the uncertainty regarding a reduction in treatment effectiveness as acceptable while others may n

39 munity residence, seems to have had the same treatment effectiveness as acute hospital care for urban

40 The kinetic parameters (epsilon, treatment effectiveness at inhibiting virion production;

41 investigate whether subjective perception of treatment effectiveness changes between the conditioning

42 clinical trials provide the best evidence of treatment effectiveness; factors determining their impac

43 have been shown to be an early indicator of treatment effectiveness for breast cancer, mainly in the

44 The discovery of biomarkers that predict treatment effectiveness has great potential for improvin

45 ome that should be evaluated as a measure of treatment effectiveness in future studies of diabetic ey

46 s should be followed up (re-examination) and treatment effectiveness in patients with specific charac

47 sumptions about pre-treatment water quality; treatment effectiveness in reducing bacteria, viruses, a

48 3) What is the evidence for treatment effectiveness in reducing depression in HF pat

49 Information regarding treatment effectiveness in this age group and tools that

50 s remain as to the selection of patients for treatment, effectiveness in fracture prevention, which b

51 Decreased treatment effectiveness is associated with biofilm forma

52 of medication adherence required for optimal treatment effectiveness is extremely high.

53 ne of therapy for this debilitating disease, treatment effectiveness is often hampered by the develop

54 to a wide range of assumptions about costs, treatment effectiveness, level of risk for cardiovascula

55 se results suggest that significant gains in treatment effectiveness may be obtained by combining the

56 ded appendectomy within 1 year, resulting in treatment effectiveness of 72.6%, significantly lower th

57 ection with a treatment cost of $100,000 and treatment effectiveness of 90%.

58 e, PRO may help to better understand overall treatment effectiveness of a new drug being tested.

59 ose To evaluate the feasibility, safety, and treatment effectiveness of ablative chemoembolization (A

60 Long-term treatment effectiveness of antiretroviral drugs is often

61 Treatment effectiveness of Helicobacter pylori varies re

62 orded the opportunity to distinguish between treatment effectiveness of SC, DH, and VC independent of

63 The authors evaluated the post-treatment effectiveness of the edge-to-edge technique us

64 Data were analyzed to compare the treatment effectiveness of the groups; data also were ag

65 een in cancers affect disease progression or treatment effectiveness or instead are benign.

66 time a link between changes in perception of treatment effectiveness, personality traits and the magn

67 n numbers of CHD patients, treatment uptake, treatment effectiveness, population risk factor trends,

68 o intravitreal injections and concerns about treatment effectiveness, rather than around pain.

69 ysician and patient visual analog scale, and treatment effectiveness score.

70 the two races; however, when controlling for treatment effectiveness, these differences were no longe

71 We examined the effect of treatment delay on treatment effectiveness using logistic regression models

72 Results also suggest that CRF treatment effectiveness was associated with cancer stage

73 Treatment effectiveness was based on adult data.

74 Treatment effectiveness was evaluated in vivo using clin

75 ression was low (<33%) and the mean reported treatment effectiveness was only moderate.

76 Estimates of treatment effectiveness were based on the JUPITER trial

77 in which early use of the new drug enhances treatment effectiveness while hastening the rise of high